Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Puissance Capital Management LP (CIK 1658437) reported $17.3M across 5 reported positions in its SEC 13F filing for 2020-09-30. Largest positions: BLPH ($11.7M, 67.74%), EKSO ($3.7M, 21.21%), SCYX ($1.4M, 7.91%), KDMN ($393,000, 2.27%), CRVS ($152,000, 0.88%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BLPH | BELLEROPHON THERAPEUTICS INC | $11.7M | 67.74% | 1.2M | Hold |
| 2 | EKSO | EKSO BIONICS HLDGS INC | $3.7M | 21.21% | 774,400 | Hold |
| 3 | SCYX | SCYNEXIS INC | $1.4M | 7.91% | 311,143 | New |
| 4 | KDMN | KADMON HLDGS INC | $393,000 | 2.27% | 100,184 | New |
| 5 | CRVS | CORVUS PHARMACEUTICALS INC | $152,000 | 0.88% | 38,010 | Hold |
| 6 | SCYX | SCYNEXIS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2020-09-30